Get started
Biomaxima SABiomaxima SABiomaxima SA

Biomaxima SA

No trades
See on Supercharts
OverviewFinancialsNewsMindsTechnicalsForecastsSeasonals

Chart


Full chart

Key stats


Market capitalization
‪54.72 M‬ PLN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
77.95
Basic EPS (TTM)
0.15 PLN
Net income (FY)
‪535.00 K‬ PLN
Revenue (FY)
‪52.85 M‬ PLN
Shares float
‪3.19 M‬
Beta (1Y)
0.08

Employees


Employees (FY)
126
Change (1Y)
+11 +9.57%
Revenue / Employee (1Y)
‪419.45 K‬ PLN
Net income / Employee (1Y)
‪4.25 K‬ PLN

About Biomaxima SA


Sector
Health Technology
Industry
Medical Specialties
CEO
Lukasz Maria Urban
Website
biomaxima.com
Headquarters
Lublin
Founded
1997
ISIN
PLBIOMX00015
FIGI
BBG000BBN6S3
Biomaxima SA operates in the field of biotechnology and laboratory diagnostics. It offers diagnostic reagents to study biochemical parameters of blood and other body fluids including analyzers, rapid diagnostic tests for the detection of infectious diseases, tumor markers, markers of myocardial infarction, and drugs. The firm also produces systems for analyzing urine, hematology reagents, and blood analyzers. The company was founded in 1997 and is headquartered in Lublin, Poland.

Check out other big names from the same industry as BMX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BMX is 12.80 PLN — it has decreased by −2.68% in the past 24 hours. Watch Biomaxima SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange Biomaxima SA stocks are traded under the ticker BMX.
BMX stock has fallen by −2.31% compared to the previous week, the month change is a −1.17% fall, over the last year Biomaxima SA has showed a −8.57% decrease.
We've gathered analysts' opinions on Biomaxima SA future price: according to them, BMX price has a max estimate of 19.10 PLN and a min estimate of 19.10 PLN. Watch BMX chart and read a more detailed Biomaxima SA stock forecast: see what analysts think of Biomaxima SA and suggest that you do with its stocks.
BMX reached its all-time high on Jul 29, 2020 with the price of 61.00 PLN, and its all-time low was 2.90 PLN and was reached on Dec 2, 2014. View more price dynamics on BMX chart.
See other stocks reaching their highest and lowest prices.
BMX stock is 1.18% volatile and has beta coefficient of 0.08. Track Biomaxima SA stock price on the chart and check out the list of the most volatile stocks — is Biomaxima SA there?
Yes, you can track Biomaxima SA financials in yearly and quarterly reports right on TradingView.
Biomaxima SA revenue for the last quarter amounts to ‪12.90 M‬ PLN, despite the estimated figure of ‪17.60 M‬ PLN. In the next quarter, revenue is expected to reach ‪15.30 M‬ PLN.
BMX net income for the last quarter is ‪−603.00 K‬ PLN, while the quarter before that showed ‪589.00 K‬ PLN of net income which accounts for −202.38% change. Track more Biomaxima SA financial stats to get the full picture.
Biomaxima SA dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 18, 2025, the company has 126 employees. See our rating of the largest employees — is Biomaxima SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biomaxima SA EBITDA is ‪4.33 M‬ PLN, and current EBITDA margin is 7.18%. See more stats in Biomaxima SA financial statements.
Like other stocks, BMX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biomaxima SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biomaxima SA technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biomaxima SA stock shows the sell signal. See more of Biomaxima SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.